Trypsin is a protease enzyme that is used in therapeutic areas like gastrointestinal disorders, viral infections and lifestyle diseases like diabetes. The adoption of trypsin has increased significantly in life sciences research and bio-pharmaceuticals production owing to its specificity in cleaving peptide bonds at carboxyl side of lysine and arginine amino acid residues. Trypsin is also known to have anti-inflammatory and anticancer properties.
The global trypsin market is estimated to be valued at US$ 42.95 million in 2021 and is expected to exhibit a CAGR of 4.3% over the forecast period 2021 to 2028.
Key Takeaways
Key players operating in the trypsin market are Promega Corporation, Merck KgaA, Geno Technology Inc., USA., Thermo Fisher Scientific Inc., SignalChem Biotech Inc., Takara Bio Inc., Creative Enzymes, ProteoChem, Waters Corporation, Bioseutica, Bovogen Biologicals Pty Ltd., and BBI Solutions
Trypsin Market Growth include substantial investments by pharmaceutical and biotech companies in R&D, development of innovative techniques like gene therapy that require trypsin, and establishing alternate trypsin production facilities in Asia and Latin America.
Trypsin companies are focusing on global expansion strategies through collaborations and acquisitions. For instance, Thermo Fisher Scientific acquired PeproTech to strengthen its cell culture portfolio. Worthington Biochemical has a strong distribution network across several countries in Europe and Asia Pacific.
Market Drivers
Growth in life sciences research and increasing expenditure on healthcare globally are anticipated to drive the demand for trypsin. With rising incidence of chronic ailments, there is a surge in the development and testing of novel biologics that rely on trypsin for various research applications. Growing biopharmaceutical industry in emerging nations of Asia and Latin America due to availability of low-cost manufacturing infrastructure and talent pool will further accentuate the trypsin market growth over the forecast period.
PEST Analysis
Political: Changes in government regulations around the use of trypsin in medical and research applications can impact the market. The market is also influenced by trade agreements and tariffs.
Economic: Economic growth and greater healthcare spending tend to increase demand for trypsin from pharmaceutical and biotechnology companies. Recessions and economic slowdowns may negatively impact the market.
Social: As the global population ages, demand is likely to increase from manufacturers of vaccines, drugs, and therapeutics that use trypsin in production processes. Growth in the biotechnology sector also supports social factors driving the trypsin market.
Technological: Advances in biochemical research and medical science lead to new applications and production methods for trypsin, supporting technological factors for market growth. High purity and effectiveness demand more technologically advanced production standards.
Geographical Regions of Concentrated Value
North America currently accounts for the largest share of the trypsin market in terms of value, led by the United States. Established biotech and pharmaceutical industries with widespread research and manufacturing activities have driven regional demand. Growth in antibody production also boosts trypsin consumption.
Fastest Growing Region
The Asia Pacific region is projected to experience the fastest growth in the trypsin market during the forecast period. This is due to improving healthcare infrastructure, expanding biologics manufacturing capabilities, and rising research intensity in nations such as China, India, and South Korea. A growing population and greater access to newer therapies will further stimulate market expansion across Asia Pacific.
Get these Report in Japanese Language:
Get these Report in Korean Language:
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
